Senseonics Holdings (id:154 SENS)
0.322 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/21/2024 2:02:53 PM)
Exchange open, closes in 1 hour 57 minutes
About Senseonics Holdings
Market Capitalization 167.77M
Senseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
| Headquarters (address) |
20451 Seneca Meadows Parkway Germantown 20876-7005 MD United States |
| Phone | 301 515 7260 |
| Website | https://www.senseonics.com |
| Employees | 132 |
| Sector | Healthcare |
| Industry | Medical Devices |
| Ticker | SENS |
| Exchange | New York Stock Exchange |
| Currency | USD |
| 52 week range | 0.275 - 0.750 |
| Market Capitalization | 167.77M |
| P/E trailing | -2.89 |
| P/E forward | -2.36 |
| Price/Sale | 7.56 |
| Price/Book | -11.48 |
| Beta | 0.795 |
| EPS | -0.130 |
| EPS United States (ID:6, base:3391) | 24.31 |